Table 1

HIV prevalence among women attending termination of pregnancy (TOP) services

Authors, publication yearPublication typeGeographical locationStudy periodTotal participants, n (TOP/delivery)Overall HIV prevalence in TOP (%)Prevalence of new HIV infections in TOP (%)HIV prevalence in women delivering (%)HIV prevalence in general population* (%)
Unlinked anonymous testing studies
Goldberg et al, 199221 ArticleDundee, Scotland1988–19906228 (1535/4693)0.850.13
Couturier et al, 199217 ArticleParis, France1990–199111 593 (2718/7261)0.70.28
Obadia et al, 199418 ArticleFrance (Southeast)1991–199211 056 (2298/7301)0.560.22
Remis et al, 199523 ArticleMontreal, Canada1989–199312 0170.180.21
Abeni et al, 199719 ArticleRome, Italy1989–1994218 357 (61 777/138 359)0.490.18
Goldberg et al, 200034 ArticleDundee, Scotland1993–199717 899 (4650/13 249)0.150.11
Drey et al, 200524 ArticleSan Francisco, USA2002–200319920.55
Thornton et al, 200722 AbstractLondon, UK2005Not available1.010.44
Carnicer-Pont et al, 201120 ArticleCatalonia, Spain1999–2006581 593 (31 904/549 689)0.130.18
Routine testing studies†
Crowe, 200826 AbstractLondon, UK2003–200716180.770.45
Creighton et al, 200925 AbstractLondon, UK2008699‡0.6
Garrard et al, 201028 AbstractLondon, UK2008–20092831‡0.52
Rosenvinge et al, 201027 AbstractLondon, UK20098440.56
Creighton et al, 201231 LetterLondon, UK2008–201143260.820.30.8
  • Articles are listed in chronological order of publication.

  • Created by the authors.

  • *Measured in the same geographical region and period.

  • †For routine testing studies, the number of participants refers to the number of women offered HIV testing in TOP settings whether they accepted or declined testing; prevalence refers to the proportion of participants who tested positive for HIV infection out of the participants who accepted HIV testing.

  • ‡Opt-out testing.